2/10
12:14 pm
hims
Hims & Hers Health (NYSE:HIMS) was given a new $31.00 price target on by analysts at Deutsche Bank Aktiengesellschaft. They now have a "hold" rating on the stock.
Medium
Report
Hims & Hers Health (NYSE:HIMS) was given a new $31.00 price target on by analysts at Deutsche Bank Aktiengesellschaft. They now have a "hold" rating on the stock.
2/10
10:04 am
hims
Hims & Hers Health: The GLP-1 Trade Just Got Real (Rating Downgrade) [Seeking Alpha]
Medium
Report
Hims & Hers Health: The GLP-1 Trade Just Got Real (Rating Downgrade) [Seeking Alpha]
2/9
08:01 pm
hims
Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]
High
Report
Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]
2/9
06:11 pm
hims
Hims & Hers Health: Don't Fall For The Hysteria [Seeking Alpha]
High
Report
Hims & Hers Health: Don't Fall For The Hysteria [Seeking Alpha]
2/9
03:05 pm
hims
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
Medium
Report
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
2/9
02:10 pm
hims
Hims & Hers Health: The Company Will Survive, But Investors Should Expect A 'Washout' [Seeking Alpha]
Low
Report
Hims & Hers Health: The Company Will Survive, But Investors Should Expect A 'Washout' [Seeking Alpha]
2/9
01:26 pm
hims
Hims & Hers Shares Plunge as Novo Files Lawsuit Amid Telehealth Firm's Regulatory Scrutiny [Yahoo! Finance]
Medium
Report
Hims & Hers Shares Plunge as Novo Files Lawsuit Amid Telehealth Firm's Regulatory Scrutiny [Yahoo! Finance]
2/9
12:09 pm
hims
Why Hims & Hers Health (HIMS) Stock Is Nosediving [Yahoo! Finance]
High
Report
Why Hims & Hers Health (HIMS) Stock Is Nosediving [Yahoo! Finance]
2/9
11:43 am
hims
Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at TD Cowen from $30.00 to $20.00. They now have a "hold" rating on the stock.
High
Report
Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at TD Cowen from $30.00 to $20.00. They now have a "hold" rating on the stock.
2/9
10:58 am
hims
Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at Citigroup Inc. from $30.00 to $16.50. They now have a "sell" rating on the stock.
High
Report
Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at Citigroup Inc. from $30.00 to $16.50. They now have a "sell" rating on the stock.
2/9
08:26 am
hims
Assessing Hims & Hers Health (HIMS) Valuation After Compounded GLP-1 Launch And Rapid Regulatory Retreat [Yahoo! Finance]
Medium
Report
Assessing Hims & Hers Health (HIMS) Valuation After Compounded GLP-1 Launch And Rapid Regulatory Retreat [Yahoo! Finance]
2/9
08:04 am
hims
Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at Bank of America Corporation from $26.00 to $21.00. They now have an "underperform" rating on the stock.
Medium
Report
Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at Bank of America Corporation from $26.00 to $21.00. They now have an "underperform" rating on the stock.
2/8
10:25 pm
hims
Hims & Hers: GLP-1 Revenues Can't Be Relied On [Seeking Alpha]
Low
Report
Hims & Hers: GLP-1 Revenues Can't Be Relied On [Seeking Alpha]
2/6
05:38 pm
hims
FDA to restrict GLP-1 ingredients used in non-approved compounded drugs [CNBC]
Medium
Report
FDA to restrict GLP-1 ingredients used in non-approved compounded drugs [CNBC]
2/6
05:23 pm
hims
FDA to restrict GLP-1 ingredients used in non-approved compounded drugs [Yahoo! Finance Canada]
Low
Report
FDA to restrict GLP-1 ingredients used in non-approved compounded drugs [Yahoo! Finance Canada]
2/5
01:53 pm
hims
Eli Lilly, Novo down as Hims to offer cheaper weight-loss pill [Seeking Alpha]
Low
Report
Eli Lilly, Novo down as Hims to offer cheaper weight-loss pill [Seeking Alpha]
2/5
11:04 am
hims
Hims and Hers Health's compounded Wegovy pill offering fuels market jitters [Yahoo! Finance]
Medium
Report
Hims and Hers Health's compounded Wegovy pill offering fuels market jitters [Yahoo! Finance]
2/5
10:23 am
hims
Instant View: Hims and Hers Health's compounded Wegovy pill offering fuels market jitters [Yahoo! Finance]
Medium
Report
Instant View: Hims and Hers Health's compounded Wegovy pill offering fuels market jitters [Yahoo! Finance]
2/5
09:00 am
hims
Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*
High
Report
Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*
2/4
05:35 pm
hims
Is Hims & Hers Health (HIMS) Attractive After The Recent Share Price Pullback [Yahoo! Finance]
Medium
Report
Is Hims & Hers Health (HIMS) Attractive After The Recent Share Price Pullback [Yahoo! Finance]
2/4
09:00 am
hims
Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care
Medium
Report
Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care
2/2
04:28 pm
hims
Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026 [Yahoo! Finance]
Medium
Report
Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026 [Yahoo! Finance]
2/2
04:05 pm
hims
Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
Medium
Report
Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
2/2
08:05 am
hims
Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at BTIG Research from $85.00 to $60.00. They now have a "buy" rating on the stock.
Low
Report
Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at BTIG Research from $85.00 to $60.00. They now have a "buy" rating on the stock.
1/30
10:05 am
hims
Hims & Hers: A Platform Strategy Pivot Driving Long-Term Value [Seeking Alpha]
Medium
Report
Hims & Hers: A Platform Strategy Pivot Driving Long-Term Value [Seeking Alpha]